lating levels of leptin are elevated in individuals suffering from chronic intermittent hypoxia (CIH). Systemic and central administration of leptin elicits increases in sympathetic nervous activity (SNA), arterial pressure (AP), and heart rate (HR), and it attenuates the baroreceptor reflex, cardiovascular responses that are similar to those observed during CIH as a result of activation of chemoreceptors by the systemic hypoxia. Therefore, experiments were done in anesthetized Wistar rats to investigate the effects of leptin in nucleus of the solitary tract (NTS) on AP and HR responses, and renal SNA (RSNA) responses during activation of NTS neurons and the chemoreceptor reflex. Microinjection of leptin (5-100 ng; 20 nl) into caudal NTS pressor sites (L-glutamate; L-Glu; 0.25 M; 10 nl) elicited dose-related increases in AP, HR, and RSNA. Leptin microinjections (5 ng; 20 nl) into these sites potentiated the increase in AP and HR elicited by L-Glu. Additionally, bilateral injections of leptin (5 ng; 100 nl) into NTS potentiated the increase in AP and attenuated the bradycardia to systemic activation of the chemoreflex. In the Zucker obese rat, leptin injections into NTS neither elicited cardiovascular responses nor altered the cardiovascular responses to activation of the chemoreflex. Taken together, these data indicate that leptin exerts a modulatory effect on neuronal circuits within NTS that control cardiovascular responses elicited during the reflex activation of arterial chemoreceptors and suggest that increased AP and SNA observed in individuals with CIH may be due, in part, by leptin's effects on the chemoreflex at the level of NTS.
nucleus of the solitary tract; leptin receptor; vagal bradycardia; chemoreceptor reflex; sympathetic nervous activity; baroreceptor reflex; chronic intermittent hypoxia CHRONIC INTERMITTENT HYPOXIA (CIH) is a common breathing disorder associated with repetitive cessation of respiratory airflow (for reviews, see Refs. 25 and 75) . Considerable data exist, suggesting that CIH may contribute to increased arterial pressure (AP) through the activation of the chemoreceptor reflex by the resulting systemic hypoxia (2, 3, 6, 7, 25, 59) . Leptin, a circulating adipocytokine produced by the adipose tissue, has been shown to be elevated during CIH (39, 46, 60, 64) , suggesting a possible link between leptin and the autonomic responses elicited by the chemoreceptor reflex. In support of this suggestion, a recent study has found that leptin injections into the nucleus of the solitary tract (NTS) alter the ventilatory response during activation of the Hering-Breuer reflex (43, 44) . Therefore, the possibility exists that leptin in NTS may also modulate the cardiovascular responses elicited during activation of the chemoreceptor reflex.
Normally, leptin is known to act centrally to decrease food intake, decrease body weight, and increase energy expenditure (10, 36, 58, 73) . The effects on energy expenditure are due to increased sympathetic nervous activity (SNA) to brown adipose tissue (40) . The increased SNA following systemic leptin administration is thought to result from the activation of central mechanisms (20, 26, 38) . Intracerebroventricular administration of leptin elicits transient increases in SNA, AP, and heart rate (HR) (38, 56, 69) . These cardiovascular effects have been suggested to be mediated by activation of hypothalamic neurons, as intra-arcuate or intra-ventromedial hypothalamic injections of leptin elicit increases in SNA and AP (52, 63) . The central leptin effects are mediated through the activation of functional leptin receptors, which are expressed in both the arcuate and ventromedial hypothalamic nuclei (52, 63, 67) . However, there are other hypothalamic nuclei, including the paraventricular nucleus and the dorsomedial hypothalamus, that also express leptin receptors (67, 68) and are involved in cardiovascular regulation (24) . Therefore, it has been suggested that leptin's effects on the cardiovascular system are mediated by descending hypothalamic pathways that regulate the activity of brain stem autonomic nuclei (24, 69) .
However, leptin may also exert its effects directly within brain stem autonomic structures as leptin receptors have been identified in the caudal brain stem, especially within the dorsal vagal complex that includes NTS (29, 30, 36, 37, 42, 53, 68) . As NTS is the primary site of termination of cardiovascular afferent fibers (14, 33, 72) , this suggests that leptin may exert an effect on NTS neurons involved in cardiovascular function. Interestingly, systemic administration of leptin has been shown to increase c-fos expression within caudal NTS regions that receive cardiovascular afferent projections (27, 30) . In addition, administration of leptin into NTS has been reported to elicit increases in AP and renal SNA (RSNA) (51) . Furthermore, leptin injections into NTS have been shown to attenuate the reflex bradycardia during systemic activation of the baroreflex (1) . These data can be interpreted to suggest that there are at least two different populations of neurons within the NTS: one population that is inhibited and one that is excited by leptin. Electrophysiological data supporting this suggestion of possible differential effects of leptin on NTS neurons have been reported (28, 76, 77) .
This study tested the hypothesis that leptin receptor activation in NTS alters the reflex cardiovascular responses to systemic activation of the chemoreceptor reflex. To test this hypothesis, experiments were done in anesthetized Wistar and Zucker leptin receptor-deficient obese rats. As chemoreceptor afferent fibers have been shown to terminate primarily within the medial (Sm) and commissural subnucleus (com) of the NTS complex (21, 31, 33, 55, 66, 72) , this region of the caudal dorsomedial medulla was initially explored for sites at which leptin microinjections altered AP and HR. Cardiovascular responsive sites were first identified with the excitatory amino acid L-glutamate (L-Glu; 15) and then tested with a microinjection of leptin at the same site. In addition, the effect of leptin on the L-Glu-evoked responses was determined at the same NTS site. Furthermore, studies were done to investigate the components of the autonomic nervous system (ANS) that mediate the cardiovascular effects to activation of NTS neurons by leptin by recording RSNA and by pharmacologically blocking the different peripheral components of the autonomic nervous system. Finally, the effect of bilateral microinjections of leptin into the caudal NTS was tested on the AP and HR responses elicited by systemic injections of potassium cyanide (KCN), which is known to activate systemic chemoreceptors (21-23, 47, 50) .
METHODS AND MATERIALS
General procedure. Experiments were done in adult male Wistar rats (250 -340 g; Charles River Canada, St. Constant, Canada; n ϭ 30), Zucker obese rats (315-385 g; Harlan Laboratories, Indianapolis, IN; n ϭ 7) and Zucker lean rats (300 -325 g; n ϭ 3). All animals were housed under controlled conditions with a 12:12-h light-dark cycle. Food and water were available to all animals ad libitum. All experimental procedures were done in accordance with the guidelines on the use and care of laboratory animals as set by the Canadian Council on Animal Care and approved by the Animal Care Committee at The University of Western Ontario.
Microinjections into the NTS. On the day of the experiments, the animals were anesthetized with ␣-chloralose (100 mg/kg iv initially and supplemented by additional doses of 10 -20 mg/kg iv every 1-2 h) after induction with equithesin (0.3 ml/100 g ip). The trachea was cannulated, and the animals were artificially ventilated using a small rodent ventilator (Harvard Apparatus; model no. 683) with a mixture of room air and 95% O2. Body temperature was maintained at 36 -37°C by a heating pad (model K-20-C; American Hospital Supply, Cincinnati, OH). Polyethylene (PE) catheters, PE-50 (Clay Adams, Parsippany, NJ), were inserted into the femoral artery and vein for the recording of AP and the administration of drugs, respectively. AP was recorded via a Statham pressure transducer (model no. P23 XL), and a Grass tachograph (model no. 7P4K) triggered by the AP pulse was used to monitor HR. AP, mean AP (MAP), and HR were recorded continuously on a Grass polygraph (model no. 79G) and in some cases using an ADInstruments PowerLab (model 4/25). In these cases, MAP and HR were calculated by ADInstruments Chart 5 Software using the AP and pulse frequency.
The head of the animal was placed in a Kopf stereotaxic frame and bent downward at a 45°angle to the horizontal meridian. The dorsal surface of the medulla was exposed by partial occipital craniotomy. The dura was cut and reflected laterally, and the caudal floor of the fourth ventricle was exposed by gently removing the vermis of the cerebellum by suction. The nervous tissue was kept moist by 0.9% physiological saline throughout the experiment. Double-barrelled glass micropipettes (tip diameter, 20 -35 m) were pulled from 5-l Socorex capillary tubing (Mississauga, ON, Canada). Micropipettes were lowered stereotaxically into the caudal NTS region using the calamus scriptorius as the reference point (rostrocaudal: 0.3 to ϩ0.5 mm; mediolateral: 0.3 to 0.7 mm; dorsoventral: 0.3 to 0.7 mm below the dorsal surface) (61) . A leptin (rat recombinant no. L-5037; Sigma, St. Louis, MO) stock solution was prepared according to the instructions supplied by Sigma and later diluted appropriately for use during the experiments by adding PBS (pH 7.2). Microinjections of leptin (5, 50, and 100 ng; 20 nl) and the excitatory amino acid L-Glu (0.25 M; 10 nl; no. G-1626; Sigma) were made into NTS using the application of pressurized nitrogen pulses controlled by a picospritzer (General Valve, Fairfield, NJ). The injected volume was measured by direct observation of the fluid meniscus in the micropipette by using a microscope fitted with an ocular micrometer, as previously described (18, 45) .
To investigate whether leptin modulated the cardiovascular responses induced by the microinjection of L-Glu into NTS, L-Glu injections were made before (control) and after (5, 10, and 30 min) injection of an amount of leptin (5 ng; 20 nl) determined to be subthreshold to elicit cardiovascular responses. This amount was chosen to minimize the possible additive effect of the systemic cardiovascular responses from each stimulus during the interaction of the two stimuli. Only NTS sites at which L-Glu elicited increases in MAP were tested for leptin's effects. Control injections of similar volumes (20 nl) of the vehicle (PBS) into these NTS sites were shown not to elicit an effect on the cardiovascular responses elicited by L-Glu.
Recording of RSNA. Following a left flank incision, a retroperitoneal dissection was used to expose the left renal nerve, as previously described (16, 70) . The renal nerves were identified coursing along the renal artery and vein, and separated from the blood vessels. The isolated renal nerves were placed on a bipolar platinum-iridium recording electrode and crushed distal to the electrode. The isolated nerves and the electrode were embedded in a silicone elastomer (Kwik-Sil; World Precision Instruments, Sarasota, FL). Additionally, cotton pellets were soaked in medical fluid (Dow Corning; Midland, MI) and placed around the nerves and other exposed tissues to prevent drying. The incision was sutured, and the animal was placed in a stereotaxic frame. The signal was amplified and passed through a Grass band pass filter (50 -3 kHz) and viewed on an oscilloscope (11) . The output of the amplifier was connected to a Grass integrator, which rectified the signal (0.5-ms time constant). The integrated and raw nerve discharges were recorded on a Grass 79 polygraph. The integrated nerve activity was then displayed as an integrated voltage that was proportional to the RSNA. The rectified signal was also recorded on a polygraph and stored on disk until analyzed using a PowerLab data acquisition system. Background noise was determined at the completion of each experiment after the systemic administration of the ganglionic blocker hexamethonium bromide (20 mg/kg iv). This value was subtracted from the integrated values obtained for each RSNA recording. Microinjections of leptin (5-100 ng; 20 nl) were made at pressor sites in the commissural NTS (com) to determine the effect of leptin on RSNA.
Effect of administration of muscarinic and nicotinic receptor blockers on the MAP and HR responses.
To determine whether the cardiovascular responses evoked by leptin microinjections (50 ng) into NTS were due to either increased SNA alone or a combination of SNA and parasympathetic nervous activity, the effect of pharmacologically blocking either component of the peripheral autonomic nervous system was determined in six anesthetized Wistar rats. These studies were not done in the Zucker lean rats as the cardiovascular responses to leptin were not different to the Wistar rats, and they were not done in the Zucker obese rats, as the previous experiments showed that no cardiovascular responses were elicited with leptin injections into NTS in these animals.
Initially, to determine whether a second injection of leptin (50 ng; 20 nl) at the same NTS site elicited a quantitatively similar AP and HR response, injections were made at 60, 90, or 120 min after the first leptin injection. The AP and HR responses were found to be of similar magnitude to the first leptin injection at all three time points. Therefore, the cardiovascular responses elicited by the microinjection of leptin (50 ng; 20 nl) were retested at 60 min after the initial leptin injection and within 5 min following the intravenous administration of either the muscarinic receptor blocker atropine methyl bromide (2 mg/kg iv) or after atropine methyl bromide in combination with the nicotinic receptor blocker hexamethonium bromide (20 mg/kg iv). Only one site in each animal was tested in these studies.
Effect of leptin in NTS on the chemoreceptor reflex. To determine whether leptin exerted an effect on the chemoreceptor reflex, the effect of microinjection of a subthreshold amount of leptin (5 ng; 100 nl) into NTS sites at which a prior injection of L-Glu elicited a pressor response, on the increased RSNA, AP, and reflex bradycardia elicited by intravenous injection of KCN (80 g/kg; 0.01 ml iv) (21-23, 47, 50) was tested in six Wistar and three Zucker obese rats. Injections of KCN were made 5 min before (control) and 5-30 min after bilateral microinjections of leptin and the vehicle into the same NTS site. In each animal, only one functionally identified NTS site was injected bilaterally during peripheral chemoreceptor activation. A larger volume of leptin was injected into NTS in these studies to increase the number of leptin receptors potentially exposed to the leptin during the injection without the leptin spreading outside the caudal NTS region.
Histological verification of injection sites. At the end of all experiments, the micropipette was withdrawn from the last site of leptin microinjection, and one barrel was emptied of either the leptin or L-Glu solution without removing it from the stereotaxic apparatus. The empty barrel was refilled with Pontamine sky blue in 0.9% saline and lowered back stereotaxically to the same site in NTS at which a 20-or 100-nl microinjection of the dye was made to mark the injection site. Injections of the Pontamine sky blue dye in saline did not elicit cardiovascular responses at the site at which the leptin previously elicited a pressor response. The animals were perfused with 50 ml of 0.9% saline solution followed by 50 ml of 10% formalin. The brains were postfixed in the 10% buffered formalin solution for 2-4 days. Frozen, transverse sections of the brain stem were cut in a cryostat at 50 m, mounted on glass slides, and stained with Neutral red. Stimulation sites were determined by extrapolation along a pipette tract from the center of the marked injection site. All stimulation sites were mapped on projection drawings of transverse sections of the rat brain stem for each animal and the atlas of Paxinos and Watson (61) was used to identify the NTS complex.
Data analysis. Responses for MAP, HR, and RSNA were expressed as the change from basal value to peak response. Means Ϯ SE were calculated for the magnitude of the peak changes in MAP, HR, and RSNA to L-Glu and leptin injections. Comparisons of the changes in MAP or HR before and after the administration of the muscarinic and nicotinic receptor blocking agents and the effects of leptin microinjections on the responses during activation of the chemoreceptor reflex were made using an ANOVA for repeated measures followed by Bonferroni post hoc test. In all cases, a P value of Ͻ0.05 was taken to indicate statistical significance.
RESULTS

Effect of microinjection of leptin into NTS on MAP, HR, and
RSNA. In the ␣-chloralose-anesthetized male Wistar (n ϭ 30), Zucker obese (n ϭ 7), and Zucker lean (n ϭ 3) rat, the MAP and HR were not different. MAP and HR in the Wistar rats were 123 Ϯ 4 mmHg and 395 Ϯ 5 bpm, respectively, whereas MAP and HR in the Zucker rats were 115 Ϯ 12 mmHg and 407 Ϯ 9 bpm, respectively. MAP (121 Ϯ 3 mmHg) or HR (403 Ϯ 5 bpm) in the Zucker lean rats was not different from those in either the Wistar or Zucker obese rat.
Microinjection of L-Glu into histologically verified sites (n ϭ 37) in the caudal NTS (Fig. 1 ) of the Wistar rat elicited increases in MAP (ϩ25 Ϯ 3 mmHg), HR (ϩ11 Ϯ 7 bpm), and RSNA (ϩ57 Ϯ 9%). Similarly, L-Glu injections in the caudal NTS sites (n ϭ 19) of the Zucker obese rat elicited increases in MAP (ϩ21 Ϯ 4 mmHg), HR (ϩ8 Ϯ 5 bpm), and RSNA (ϩ51 Ϯ 7%) that were not different in magnitude from those elicited in the Wistar rat. L-Glu injections in the Zucker lean rat elicited increases in MAP (ϩ18 Ϯ 7 mmHg), HR (ϩ5 Ϯ 3 bpm), and RSNA (ϩ62 Ϯ 11%) that were not different in magnitude from those elicited in the other two groups. Control injections of vehicle made at some these sites within the NTS of Wistar (n ϭ 18) and Zucker obese (n ϭ 9) rats did not elicit cardiovascular responses (MAP, Ϫ2 Ϯ 5 mmHg; HR, 3 Ϯ 7 bpm; RSNA, Ϫ 5 Ϯ 10%).
On the other hand, at the same NTS sites at which an injection of L-Glu elicited a pressor response (Fig. 1) , leptin injections elicited an increase in MAP, HR, and RSNA in the Wistar rat (Fig. 2 ) that was dose-related ( (Fig. 2) .
Pressor sites were localized primarily within the medial (Sm), commissural (com), and gelatinosa (Sg; subpostrema area) subnuclei of the caudal NTS complex (Fig. 1) . The location of L-Glu-responsive sites in the Wistar and Zucker lean rats in which leptin also elicited cardiovascular responses was similar to that in the Zucker obese rats in which leptin had no effect (Fig. 1) .
Effect of microinjection of leptin into NTS on L-Glu evoked MAP and HR responses.
Injection of 5 ng (20 nl; n ϭ 11) of leptin at L-Glu pressor sites (MAP, ϩ23 Ϯ 3 mmHg; HR, ϩ6 Ϯ 4 bpm; RSNA, ϩ55 Ϯ 5%) did not elicit changes in MAP or HR in the Wistar rats (Fig. 3, A and B) . The increases in MAP (P Ͻ 0.016; Fig. 4A ), and RSNA (P Ͻ 0.019; Fig. 4C ) responses induced by L-Glu, however, were significantly potentiated at 10 min after microinjection of leptin at the same site. The magnitude of these L-Glu responses was not different from control at 30 min after the leptin injection. The effect of leptin on the HR response was found not to be statistically different (P Ͻ 0.08). However, it was apparent that after the leptin injection, L-Glu consistently elicited a greater increase in HR at the 10-min time point (Fig. 4B) . The HR responses prior to the leptin injection were variable. The variance between control responses and those at the 10-min time point for HR was found to be statistically significant (P Ͻ 0.009). The data from all experiments are summarized in tions of the vehicle at pressor sites (n ϭ 10) did not alter the magnitude of either the MAP (ϩ19 Ϯ 5 mmHg), HR (ϩ8 Ϯ 3 bpm), or RSNA (ϩ50 Ϯ 5%) responses to L-Glu injections into NTS.
At some sites (n ϭ 7) within the caudal Sm subnucleus of NTS at the level of the area postrema (Fig. 5, A and B) , a biphasic MAP response (a decrease of Ϫ18 Ϯ 5 mmHg followed by an increase of ϩ12 Ϯ 7 mmHg) was evoked after microinjection of L-Glu, that was accompanied with a decrease in HR (Ϫ35 Ϯ 7 bpm) (Fig. 5, C and D) . After microinjection of leptin at these sites, the biphasic response to L-Glu was changed into a pressor response only (ϩ21 Ϯ 5 mmHg), and the decrease in HR was significantly attenuated (Ϫ18 Ϯ 5 bpm; P Ͻ 0.05). This effect of leptin on the L-Glu MAP-and HR-induced responses occurred at about 10 -15 min after the leptin injection into NTS. At 30 min after the leptin injections, a similar biphasic response was elicited from the same site with L-Glu (a decrease of Ϫ15 Ϯ 7 mmHg followed by an increase of ϩ13 Ϯ 9 mmHg) and a decrease in HR (Ϫ23 Ϯ 7 bpm). A representative experiment is shown in Fig. 5 .
Components of the peripheral autonomic nervous system mediating the MAP and HR responses to microinjection of leptin into NTS.
To investigate whether changes in parasympathetic nervous system activity contributed to the AP and HR D) . Calibration mark in A of 0.1 mm applies to both A and B. Note in C-E that the control response to L-Glu at the NTS site was a decrease in both AP and HR. Injection of leptin at the same site did not elicit significant cardiovascular changes. On the other hand, both the decreases in AP and HR were attenuated to L-Glu at 5-15 min after the leptin injection, and the responses returned to control values by 30 min. Also note that the secondary rise in AP during the biphasic response was increased at 5-15 min after the leptin injection.
responses elicited by leptin, the muscarinic receptor blocker atropine methyl bromide was administered intravenously. The HR response elicited by leptin microinjection was attenuated by ϳ28% (P Ͻ 0.05), while the MAP was not altered (Fig. 6) . In contrast, following the subsequent administration of the ganglionic blocker hexamethonium bromide, the remaining HR and the MAP responses were abolished (Fig. 6) .
Effect of bilateral microinjections of leptin on chemoreflex cardiovascular responses. The effects of leptin microinjection into caudal NTS pressor sites were investigated following activation of peripheral chemoreceptors in both the Wistar and Zucker obese rat. Acute intravenous injections of KCN elicited an increase in MAP (ϩ53 Ϯ 5 mmHg) and RSNA (ϩ56 Ϯ 3%), and a decrease in HR (Ϫ68 Ϯ 4 bpm) in the Wistar rats (Fig. 7) . KCN injections in the Zucker obese rat elicited responses of similar magnitude (MAP, ϩ51 Ϯ 5 mmHg; RSNA, ϩ58 Ϯ 10%; HR, Ϫ57 Ϯ 7 bpm). Control injections of the same volume of saline in both the Wistar and Zucker obese rats did not elicit MAP (ϩ3 Ϯ 5 mmHg), HR (ϩ5 Ϯ 5 bpm) responses, or changes in RSNA (ϩ4 Ϯ 5%).
In the Wistar rats, 10 min after a bilateral injection of leptin into NTS, the magnitudes of the MAP and RSNA responses were significantly (P Ͻ 0.05) potentiated compared with control levels (Figs. 7 and 8) . On the other hand, the bradycardia response was attenuated starting at 5 min, with a maximal effect observed at 10 min after the leptin injection (Figs. 7 and  8 ). All responses evoked by the activation of the peripheral chemoreceptors returned to preleptin injection values by 30 min. A representative experiment is shown in Fig. 7 , and these data are summarized in Fig. 8 . Similar effects were observed in the Zucker lean rat. At the 10-min time point after the leptin injection, both the MAP and RSNA were greater by ϩ22 Ϯ 5 mmHg and ϩ28 Ϯ 5%, respectively, compared with control KCN alone response, while the HR response was attenuated by Ϫ37 Ϯ 9 bpm compared with control KCN alone response. Compared with the effect of leptin on the cardiovascular responses elicited by activation of the chemoreflex in the Wistar and Zucker lean rats, leptin injections into NTS of the Zucker obese rats did not alter the cardiovascular responses to KCN injections. At the 10-min time point, the MAP (ϩ53 Ϯ 4 mmHg), RSNA (ϩ73 Ϯ 8%), or HR (Ϫ83 Ϯ 5 bpm) to KCN injections were similar to those elicited prior to the leptin injection.
DISCUSSION
This study has provided the first evidence of an effect of leptin in NTS on the cardiovascular responses evoked by systemic activation of the chemoreceptor reflex. Discrete microinjections of leptin into caudal NTS pressor sites elicited a dose-related increase in MAP, HR, and RSNA. The MAP response was due to increased SNA as peripheral ganglionic blockade abolished the responses. On the other hand, the HR response was due to both parasympathetic inhibition and sympathetic excitation, as the HR response was attenuated following muscarinic receptor blockade and abolished after total autonomic blockade. Additionally, leptin not only potentiated the cardiovascular responses elicited by L-Glu injections at the same NTS site, but also potentiated the cardiovascular responses resulting from the activation of peripheral chemoreceptors. These novel findings of leptin's actions on the reflex cardiovascular responses evoked by activation of the chemoreceptor reflex have considerable implications in the understanding of the contribution of leptin to autonomic changes during conditions of systemic hypoxia, especially as during CIH, leptin levels have been reported to be elevated (39, 46, 64) , suggesting that these elevated levels of leptin may contribute to the resulting hypertension. The finding in this study that leptin exerts an effect on cardiovascular regulatory systems in NTS independent of the hypothalamus is consistent with a number of recent studies showing that leptin can have a direct effect on brain stem neuronal systems. Systemic injections of leptin have been shown not only to increase c-fos expression (27, 30) but also increase STAT3 expression, which is indicative of activation of functional leptin receptors within NTS (42) . Consistent with this latter interpretation of direct actions of leptin within NTS, leptin receptors have been identified within the nucleus, primarily within the cardiovascular responsive aspects of the caudal NTS complex (29, 30, 36, 37, 42, 53, 68) . In addition, both in vivo and in vitro studies recording the electrical activity of neurons within NTS have shown that leptin can either directly activate or inhibit the discharge frequency of these neurons (28, 76, 77) . Furthermore, direct injections of leptin into NTS have been reported to elicit increases in AP and RSNA (51) . However, although these latter observations are consistent with the data obtained in this study, it should be noted that in the study by Mark et al. (51), lower amounts of leptin in a larger volume were injected into the NTS compared with this study. Thus, the smaller increases in MAP observed in this earlier study (51) , along with the longer time course to observe the pressor effect (51), may reflect the fact that a larger number of neurons were likely needed to be recruited within the NTS injection site to induce an increase in sympathetic activity. On the other hand, the higher amount in the small focal injection in this study likely activated a sufficient group of neurons to elicit the cardiovascular responses. Finally, injections of leptin into NTS have been shown to attenuate the reflex vagal bradycardia during systemic activation of the baroreflex (1). The putative effects of leptin within NTS on the cardiovascular system are also supported by studies demonstrating similar actions of leptin in NTS on gastric function (37) .
Central administration of leptin has been shown to elicit a dose-dependent increase in AP (20) . Thus, the finding that leptin injections into NTS also elicited a dose-related increase in MAP was not unexpected, especially as a similar finding in NTS has been previously described (51) . That the MAP response was accompanied by an increase in RSNA and it was blocked following total peripheral ganglionic blockade indicates that the MAP was mediated by increased SNA to the vasculature. The finding of increased RSNA is also consistent with the work of Mark et al. (51) , showing that leptin injections into NTS elicited increases in RSNA. On the other hand, the tachycardia response elicited by leptin was found to be attenuated after systemic administration of the muscarinic receptor blocker atropine methyl bromide and abolished following the additional administration of the nicotinic receptor blocker hexamethonium bromide. These data suggest that the HR response to leptin was mediated, in part, by an inhibition of vagal activity and an activation of SNA to the heart. This latter finding is consistent with the observation by Arnold et al. (1) , showing that leptin inhibited the vagal component of the baroreceptor reflex.
Similar to a previous report (51) , this study has shown that leptin injections into NTS in the Zucker obese rat did not elicit cardiovascular responses. On the other hand, injections in the Wistar rat in this study, like injections in both the Zucker lean rat and Sprague-Dawley rat (51), elicited increases in MAP and RSNA. This study not only confirms the earlier findings, but it also supports the suggestion that to evoke leptin-induced cardiovascular responses from NTS require functional leptin receptors (51) .
In this study, sites that elicited pressor responses to both L-Glu and leptin were found within the caudal Sm, com, and Sg subnuclei of the NTS complex from the level of the caudal third of the area postrema to just caudal to the calamus scriptorius. This region of NTS has been previously shown to be the primary site of termination of chemoreceptor afferents (33, 55, 66, 71, 72) . In addition, activation of peripheral chemoreceptors has been shown to induce increased c-fos expression within this region of NTS (21, 22, 31, 33) . Activation of chemoreceptor afferents elicits increases in MAP and SNA, and a decrease in HR similarly in anesthetized and awake animals (12, 13, 22, 23, 35, 47, 50) . Similar MAP and SNA responses are elicited by injection of excitatory amino acids into these regions of NTS in both anesthetized and awake animals (12, 19, 74) , which were also observed in this study. These findings, taken together, with the observation in this study that leptin potentiates both the responses elicited by L-Glu in NTS and those due to activation of the peripheral chemoreceptor reflex, suggest that neurons found within caudal NTS complex contain functional leptin receptors and are activated by leptin (65) and that these NTS neurons are likely involved in mediating the cardiovascular responses to activation of the chemoreceptor reflex. The possibility that leptin is exerting an effect not only on secondary neurons within NTS that receive primary afferent inputs but is also exerting a direct effect on primary chemoreceptor afferents cannot be completely eliminated, as leptin receptors have been identified on vagal afferent fibers (8, 54, 62) . However, how leptin gains access to NTS neurons expressing the leptin receptor is unknown, as these neurons are located within the blood-brain barrier. It is likely that leptin within the circulation reaches NTS neurons, as it does in other central nervous sites, through a saturable, dose-dependent leptin transporter system (4, 5, 32) . However, it is interesting to note that some components of the NTS complex, especially the Sg, along with the dorsal aspect of the Sm and the com, contain numerous fenestrated capillaries. This organization is not unlike that within the median eminence and arcuate nucleus of the hypothalamus (57) . In this study, most of the sites that were found to elicit leptin's effects on the circulation and on the chemoreflex were found within the Sg, Sm, and com. Thus, the possibility exists that leptin reaches neurons within these subnuclei of the NTS complex directly through the circulation. This suggestion is supported by the observations that neurons within the Sg and dorsal Sm and com are labeled following the systemic injections of dyes, such as horseradish peroxidase and Fluorogold (34, 48, 57) , suggesting that these NTS leptin-sensitive neurons may have direct contact with the circulation via neuronal processes that lie outside the blood-brain barrier (32, 57) .
The cellular mechanism by which leptin alters the activity of NTS neurons is not known, and it is likely that leptin depolarizes the resting membrane potential (41, 76, 77) . In the interaction experiments in this study, an amount of leptin subthreshold to that needed to elicit cardiovascular responses was used to minimize the possibility that the interaction effects were not simply due to summation of the responses, but rather a potentiation of the responses due to activation of greater number of NTS neurons. Activation of chemoreceptors, depending on the magnitude of the stimulus, is known to activate some NTS neurons, while only partially depolarizing others within a subliminal fringe. Thus, the potentiation of the chemoreceptor cardiovascular responses observed in this study was likely the result of both the leptin and the chemoreceptors afferents not only causing the discharge of some NTS neurons, but also causing each stimulus to exert a partial depolarizing effect on other NTS neurons. When both stimuli were applied together, these partially depolarized neurons were brought to discharge. Thus, the increase in the magnitude of the circulatory responses was likely due to the increased activity of NTS neurons to brain stem sympathoexcitatory neuronal circuits (17, 72) .
This study focused on identifying the effects of leptin on the sympathetic responses mediated by NTS. However, it is also well known that NTS is the primary site of termination of baroreceptor-afferent fibers in the medulla (14, 72) . Although the effects of leptin on these depressor sites were not investigated in this study, as previously reported (1), it would be expected that leptin injections would have attenuated the vagal responses elicited during activation of the baroreceptor reflex. Consistent with this suggestion, it was found in this study that the bradycardia elicited by chemoreceptor activation was also attenuated, thus suggesting that neurons mediating the vagal bradycardia may be sensitive to the effects of leptin (1). In addition, at some sites in NTS where a biphasic response was elicited by L-Glu injections, the depressor component of the AP response was abolished, while the HR response was attenuated after injection of leptin at the same site. This suggests that leptin may exert an effect not only on the vagal HR component of the baroreceptor reflex (1), but also on the sympathoinhibitory AP component of the baroreceptor reflex. This latter possibility is supported by an observation previously reported from this laboratory showing that leptin injections in NTS inhibit both the HR and AP response to baroreceptor activation (15) . In addition, we have recently observed that leptin injections into NTS attenuate the depressor response to stimulation of aortic baroreceptors afferents (Ciriello J, unpublished observations). As leptin appears to have an inhibitory effect on the baroreflex, it may be argued that the potentiation of the MAP and HR responses to chemoreceptor activation or to L-Glu injections into NTS were due to inhibition of the baroreflex. Thus, removal of the inhibitory effects of the baroreflex on sympathoexcitatory systems in the medulla would result in an increased sympathetic drive. Although this possibility cannot be completely excluded, the time course of the increased RSNA seen in this study and that previously reported by Mark et al. (51) suggests it is likely that both the excitation of sympathoexcitatory systems and inhibition of sympathoinhibitory systems occur during leptin administration within NTS.
Perspectives and Significance
It is well known that systemic hypoxia leads to activation of peripheral chemoreceptors as a result of decreased partial pressure of oxygen within the circulation. Recent studies have reported that individuals who suffer from CIH have increased SNA and MAP (25) . The resulting hypertension is thought to be the result of activation of peripheral chemoreceptors (25) . Interestingly, individuals suffering from CIH have also been shown to have high circulating levels of leptin independent of their body weight (39, 46, 60, 64) . Thus, it is not unreasonable to suggest that the higher circulating levels of leptin may contribute to the hypertension in these patients by altering the sensitivity of the chemoreceptor reflex at the level of NTS. The findings of this study have shown leptin exerts an effect on NTS neurons that leads to a potentiation of the AP and SNA observed during application of hypoxic stimuli. Although the mechanisms involved in this effect are not known, it is likely that the effects of leptin on the chemoreflex, in combination with its effects on the baroreceptor reflex, contribute to the hypertension observed in patients with CIH (6, 25, 49) .
